Not Yet Recruiting
High-dose Furmonertinib Versus Osimertinib in Advanced EGFRm NSCLC Patients With Brain Metastases
NCT06319950
- Conditions
- Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
- Locations
-
Not specified